Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Oct 21 2022

Full Issue

Drugmakers Seeking Some Relief On New Medicare Rules

The Inflation Reduction Act, which allows Medicare to negotiate the prices of some drugs, was strongly opposed by drugmakers and one of their very rare losses on Capitol Hill. They are now hoping to help influence the Biden administration as it sets the regulations from the new law.

The Wall Street Journal: Drugmakers Look To Limit Medicare’s New Power To Negotiate Lower Drug Prices

Drugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing influence in Washington, D.C. Under the Inflation Reduction Act, Congress gave Medicare, the country’s biggest buyer of prescription drugs, the authority to negotiate how much it pays for certain high-price therapies, and to get rebates on treatments whose prices rise more than the rate of inflation. (Hopkins, 10/20)

Stat: Medicare Will Soon Cap Drug Spending. There’s No Limit For Hospital Bills

By 2025, people on Medicare who take expensive medications will feel significant financial relief: They will not have to pay more than $2,000 in a year for all of their drugs. But the 35 million people who are enrolled in the traditional Medicare program still won’t have that same relief anytime soon for their hospital, outpatient, home health, and nursing home care, leaving them exposed to potentially unlimited costs if they become seriously ill and don’t have supplemental coverage. (Herman, 10/21)

Meanwhile, Ohio and Kentucky make some changes to Medicaid, the federal-state programs for people with low-incomes —

Columbus Dispatch: Ohio Rolls Out Single Pharmacy Benefit Manager

Advocates say having a single pharmacy benefit manager will prevent millions of taxpayer dollars from being overcharged. The launch is arguably the most-watched recent reform to Medicaid, which provides government-funded health care for nearly 3 million low-income people ‒ or nearly 1 in 4 Ohioans. (Wu, 10/20)

AP: Kentucky Offers Expanded Medicaid Health Coverage For Adults

Gov. Andy Beshear on Thursday extended Medicaid coverage for dental, vision and hearing care to hundreds of thousands of Kentucky adults, saying the sweeping initiative will remove some of the health-related obstacles keeping people from getting jobs. (Schreiner, 10/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF